黄素对类风湿性关节炎的影响:系统性审查和元分析
Haiyang Kou1, Lei Huang1, Meng Jin1
1Department of Joint Surgery, Translational Medicine Center, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Frontiers in immunology
|June 16, 2023
概括
黄素补充剂显著减少了类风湿性关节炎患者的炎症和临床症状. 建议进行进一步的大规模试验,以证实黄素在类风湿性关节炎治疗中的这些有益作用.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 自然产品化学 自然产品化学
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,其特点是关节炎症和渐进性关节损伤.
- 目前的RA治疗旨在控制症状并减缓疾病的进展,但许多患者会经历持续的炎症和副作用.
- 黄是一种来自黄的天然化合物,具有已知的抗炎和抗氧化特性,可能有利于RA患者.
研究的目的:
- 系统评估黄素补充剂在治疗类风湿性关节炎中的有效性和安全性.
- 综合现有关于黄素对关键RA疾病标志物和临床结果的影响研究的证据.
主要方法:
- 在PubMed,Embase,Cochrane图书馆和Web of Science数据库中进行了全面的文献搜索,截至2023年3月3日.
- 经过严格的查和数据提取,包括了涉及539名类风湿性关节炎患者的6篇相关出版物.
- 偏差风险评估是使用Cochrane手册指南进行的.
主要成果:
- 与对照组相比,黄素补充剂导致红细胞沉率 (ESR),疾病活性评分 (DAS28),胀关节数 (SJC) 和柔软关节数 (TJC) 的统计显著降低.
- 这些发现表明炎症标志物和类风湿性关节炎的临床症状显著改善.
- 在包括的研究中没有详细说明与黄素相关的特定不良事件,这表明它具有有利的安全性.
结论:
- 黄素通过减轻炎症和改善临床症状,在治疗类风湿性关节炎方面显示出显著的益处.
- 黄素补充剂对于类风湿性关节炎患者来说是一个有前途的治疗选择.
- 未来的研究应该专注于大规模的随机对照试验,以进一步验证黄素在 RA 治疗中的有效性和安全性.
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
202
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
202
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K


